Company: IRadimed Corporation
Ticker: Nasdaq: IRMD
Sector: Healthcare
Investor Contact: Joe Dorame

IRadimed Corporation News

News

IRADIMED CORPORATION Reports Unaudited Fourth Quarter and 2023 Revenue

Reports preliminary fourth quarter 2023 revenue of $17.5 million WINTER SPRINGS, Fla., Jan. 09, 2024 -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD), a leader in developing innovative Magnetic Resonance Imaging ('MRI") compatible medical devices, today reported...

IRADIMED CORPORATION Announces Third Quarter 2023 Financial Results

Reports record revenue of $16.5 million for the third quarter of 2023.GAAP diluted EPS of $0.40 and non-GAAP diluted EPS of $0.43.Third quarter operating income of $5.9 million, an increase of 43% compared to the same period in 2022. WINTER SPRINGS, Fla., Nov. 03,...

Skip to content